NCT03550261View on ClinicalTrials.gov

Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 17, 2018

Primary Completion Date

November 15, 2021

Study Completion Date

November 15, 2021

Conditions
Congenital Adrenal Hyperplasia (CAH)
Trial Locations (1)

75019

Hôpital Robert Debré, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03550261 - Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia | Biotech Hunter | Biotech Hunter